OKYO Pharma

OKYO · NASDAQ

$1.37−$0.03 (−2.14%)TodayMarket closed ·
Prev close $1.40

Latest news

  • Press releaseGlobe Newswire

    OKYO Pharma to Present at Ophthalmology Futures European Forum and iNovation Day at ESCRS 2026

  • Press releaseGlobe Newswire

    OKYO Pharma to Participate in a Fireside Chat at the Cantor Global Healthcare Conference

  • News

    OKYO Pharma Announces Positive Feedback From FDA Type D Meeting, Validating Regulatory, Clinical Path Forward For Urcosimod And Supporting Advancement Into Global Phase 3 Pivotal Trial For NCP

  • Press releaseGlobe Newswire

    OKYO Pharma Reports Positive Feedback from FDA Type D Meeting and Accelerates Urcosimod into Global Phase 3 Pivotal Trial for Neuropathic Corneal Pain

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • News

    12 Health Care Stocks Moving In Friday's After-Market Session

  • News

    12 Health Care Stocks Moving In Friday's Intraday Session

  • News

    12 Health Care Stocks Moving In Friday's Pre-Market Session

  • Press releaseGlobe Newswire

    OKYO Pharma Announces Pricing of $20 Million Public Offering of Ordinary Shares

  • News

    12 Health Care Stocks Moving In Thursday's After-Market Session

  • Press releaseGlobe Newswire

    OKYO Pharma Announces Public Offering of Ordinary Shares

  • Press releaseGlobe Newswire

    OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer

  • Press releaseGlobe Newswire

    OKYO Pharma Receives $1.9 Million in Non-Dilutive Funding to Accelerate Development of Urcosimod for Neuropathic Corneal Pain

  • Press releaseACCESS Newswire

    Goldman Small Cap Research Issues New Research Update on OKYO Pharma Limited

  • Press releaseGlobe Newswire

    FDA Grants OKYO Pharma Fast Track Designation to Urcosimod for Neuropathic Corneal Pain

  • News

    12 Health Care Stocks Moving In Wednesday's Pre-Market Session

  • News

    3 Health Care Stocks Moving In Thursday's Intraday Session

  • NewsAvi Kapoor

    Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.